GlassScriptPhysician profile
Chad Charles Ward
NPI 1902245004
$125,648.86
in general payments reported to CMS, 2019-2025
38 companies · $17K in 2025
The $17K reported for 2025 was more than what 87% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $3,934 · 2021: $9,057 · 2022: $34K · 2023: $17K · 2024: $19K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Travel and Lodging: $19K · Honoraria: $10K · Consulting Fee: $3,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20,121.35 |
| Travel and Lodging | $18,760.00 |
| Honoraria | $10,400.00 |
| Consulting Fee | $3,350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $57,079.04 | 2019-2025 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Sentus |
| Impulse Dynamics (USA) INC. | $15,069.78 | 2022-2025 | Optimizer, Optimizer |
| Boston Scientific Corporation | $13,233.08 | 2019-2025 | Watchman Flx, Farapulse, Cds - Mct/Cem Monitoring |
| Abbott Laboratories | $11,874.19 | 2019-2025 | Aveir, Gallant, Ensite |
| Medtronic Vascular, INC. | $8,318.42 | 2019 | |
| Medtronic, INC. | $6,144.30 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Medical Device Business Services, INC. | $2,951.81 | 2021-2023 | Carto 3 |
| Biosense Webster, INC. | $2,703.36 | 2019-2025 | Carto 3, Qdot Micro Catheter, Qdot Micro |
| Philips North America LLC | $2,675.12 | 2019-2025 | (Ck4) Mcot, Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und |
| Cvrx, INC. | $1,121.76 | 2022-2025 | Barostim Neo System |
| Atricure, INC. | $977.80 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Altathera Pharmaceuticals LLC | $756.55 | 2023-2024 | Sotalol Hydrochloride |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $456.10 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $369.62 | 2021-2025 | |
| Amgen INC. | $357.18 | 2021-2025 | Repatha |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.